Roy Auty is a highly experienced executive with a background in pharmaceuticals and a focus on pipeline and portfolio planning. Auty completed his MBioch in Biochemistry at the University of Oxford and followed it up with a PhD in Biological Chemistry and Molecular Pharmacology at Harvard Medical School.

Auty has spent time at several leading companies within the pharmaceutical industry, including Genentech and Pfizer. Notably, he was the former Associate Director, Pipeline/Portfolio Planning at Genentech and the former Director of Business Operations, Medical Affairs, Global Innovative Pharma Business at Pfizer.

Currently, Auty serves as the Head of Portfolio Operations & Strategic Projects at Roche. His role involves overseeing portfolio operations and leading strategic projects.

Throughout his career, Auty has demonstrated his skillset in both strategy and innovation. His experiences at Pfizer and Genentech, in particular, have strengthened his abilities in pipeline and portfolio planning. Overall, Auty's extensive experience in the pharmaceutical industry signifies his elevated understanding of drug development and project management.